Quarterly report pursuant to Section 13 or 15(d)

Basic and Diluted Net Income (Loss) Per Share (Tables)

v3.22.2
Basic and Diluted Net Income (Loss) Per Share (Tables)
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following securities were excluded due to their anti-dilutive effect on net loss per common share recorded for the periods presented:

 

 

 

Three and Six Months Ended June 30,

 

 

 

2022

 

 

2021

 

Stock options outstanding

 

 

403,750

 

 

 

561,079

 

Unvested stock options early exercised

 

 

323,475

 

 

 

442,974

 

Unvested performance-based stock options early exercised

 

 

375,000

 

 

 

375,000

 

Redeemable convertible preferred stock

 

 

 

 

 

8,384,906

 

Warrants to purchase common stock

 

 

450,396

 

 

 

403,698

 

Restricted stock units outstanding

 

 

859,264

 

 

 

 

Total

 

 

2,411,885

 

 

 

10,167,657